Ranbaxy Laboratories Limited (Ranbaxy) is a research based international pharmaceutical company serving customers in over 150 countries. For more than 50 years, we have been providing high quality, affordable medicines trusted by healthcare professionals and patients across geographies.
We have ground operations in 43 countries and 21 manufacturing facilities spread across 8 countries. We cover all the top 25 pharmaceutical markets of the world and have a robust presence across both developed and emerging markets.
Offering High Quality, Affordable Pharmaceuticals
We are a vertically integrated company that develops, manufactures and markets Generic, Branded Generic, Value-added and Over-the-Counter (OTC) products, Anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates. We have a large portfolio of over 500 molecules that cover multiple dosage forms including tablets, capsules, injectables, inhalers, ointments, creams and liquids. Our presence extends across therapies and includes Anti-infectives, Cardiovascular, Pain management, Central Nervous System (CNS), Gastrointestinal, Respiratory, Dermatology, Orthopaedics, Nutritionals and Urology. Biotech and Vaccines are two new segments that we have begun investing in. A stronger presence in these areas will add significant depth to the existing product pipeline.
Through our unique hybrid business model involving Daiichi Sankyo, we also introduce innovator products in markets around the world.
Driven by Innovation
Our continued focus on Research & Development (R&D) has resulted in several regulatory approvals in both developed and emerging markets. We have multiple R&D centres in Gurgaon, Haryana, India with facilities for generic and innovative research. Our scientists have given India its first New Chemical Entity (NCE) that was launched on April 25, 2012. The product, SynriamTM, is a new age cure for Malaria. With a strong focus on research in generics, we are increasingly working on more complex and specialised areas.
Our business philosophy, based on delivering value to our stakeholders, constantly inspires our people to innovate, excel and set new global benchmarks. Our multicultural workforce, comprising more than 14,600 employees of over 50 nationalities, gives us the strength to make quality healthcare accessible to people around the world. We remain committed to aggressively pursuing our mission of ‘Enriching lives globally, with quality and affordable pharmaceuticals’.